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) and excluded nonpaternity using several polymorphic markers on different chromosomes. In adthree cytoplasmic domains are spread out in the E1 conformation and grouped compactly in E2. The nucleodition, cases 3 (de novo) and 4 had the same mutation (T613M; C1838T), but haplotype analysis across the distide (N) domain (green) emerges from the P domain via a hinge and folds down over the P domain in the E2 ease gene region confirmed that these were independent events. All six mutations are located in highly conconformation ( Expression of the protein was obtained in all of the mutants, but levels of expression were reduced and seemed to follow the same pattern observed in the cell viability assays (Figure 4) . These observations are consistent with reduced stability and lower recovery of mutant forms. Consequently, both functional deficits and reduced level may contribute to the failure to replace ␣1 activity.
To assess whether the localization of mutant pumps was different from WT pumps, we conducted immunofluorescence studies using Xpress-tagged (Invitrogen) WT, WT-OR, and mutant OR ␣3 constructs transiently transfected into HEK293 cells and found no remarkable differences (data not shown). In accordance with other studies (Takeyasu et al., 1988) in which exogenous ␣ subunit is expressed without additional exogenous ␤ subunit, much of the nascent a3 appears in ER and Golgi, but some was observed at the plasma membrane for all mutant and WT constructs. Qualitatively, this indicates that none of the mutations disrupted the maturation of the Na ϩ /K ϩ -ATPase.
To date, there is no evidence of widespread neurodegeneration in patients with RDP, but further studies are necessary to assess this hypothesis. The clinical course of the majority of the patients, with acute onset of symp- Figure 3) . It is unlikely that the would in principle make dominant-negative mutations mutations created in the constructs to confer ouabain possible. All of the RPD mutated residues, however, are resistance interact with the RPD mutations to reduce predicted to be buried in one or both conformations, activity or enhance ouabain sensitivity, because equivaand nothing about them predicts a role in subunit interlent mutations in ␣1, ␣2, and ␣3 have not been observed actions. The expression studies predict that, in RDP, ␣3 to impair function in other mutagenesis studies. Addiactivity and expression will be reduced, with a result equivalent to haploinsufficiency. How this results in the tionally, the ouabain binding mutations are at the extra- Table 1 . Informed consent was obtained, and the study was approved by the various instituOuabain Treatment tional review boards. Cells were distributed in nine 100 mm plates and were transfected between 70%-80% confluence. One plate was transfected with the wild-type ouabain-sensitive (␣3-WT) cDNA, two plates were transMutation Screening fected with cDNAs modified only to obtain ouabain resistance (␣3-DNA was extracted from white blood cells or buccal cells using OR), and six plates were transfected with ␣3-OR cDNAs containing standard methods. The 23 exons of the ATP1A3 gene were amplified each one of the patient mutations described above. Transfection (primers and conditions in Supplemental Table S1 [http://www. efficiency was assessed by cotransfection of pDsRed-Express-N1 neuron.org/cgi/content/full/43/2/169/DC1]) and the products seVector (Clontech) and estimated at 70%. To inhibit the endogenous quenced by standard dideoxy nucleotide sequencing. For each sodium pump activity, transfected cells were fed medium containing identified mutation, we screened 500 control chromosomes by de-10 M ouabain 36 hr after transfection. One plate transfected with naturing high performance liquid chromatography (DHPLC) using ␣3-OR was fed medium without ouabain and was used as a control the WAVE Nucleic Acid Fragment Analysis System (Transgenomic, of the expected number of cells. Two days after the ouabain chalOmaha, NE). Elution gradients and analysis temperatures for each lenge, the surviving cells were resuspended and counted with a exon were predicted based on the target sequence using the Transhemacytometer (Fisher Scientific, Co.), and an estimation of cell genomic WAVEMaker software (Table S1 ). Mutation positive and death in each group was obtained by comparing the number of negative controls were used in all runs.
surviving cells to those of the control group. The experiment was repeated four times. In order to verify that the differences in cell death numbers between the ␣3-OR cultured in ouabain and the Genotyping other ␣3-OR mutants was significant, a 2 test was performed, and For confirmation of potential de novo mutations, screening for nona p value Յ0.05 was considered significant. paternity was performed in the probands and their parents with the following polymorphic markers: D19S223, D19S400, D19S 417, D19S 420, D19S 408, D17S785, D18S 976, GATA171C12, D4S2431, Western Blot Protein (50 g) from transfected and untransfected cell lysates was D4S3028, and D4S1607. Primers and amplification conditions were as specified at www.gdb.org and http://www.chlc.org/. The same loaded in 7.5% Tris-HCl polyacrylamide gels. SDS-PAGE was performed for 2 hr at 100 V. For ATP1A3 detection, transblotted nitrocelmarkers on chromosome 19 were used for haplotype analysis of patients who shared the same mutation. Products were analyzed lulose membranes were incubated with the ␣3-specific XVIF9-G10 monoclonal antibody (Affinity Bioreagents, Golden, CO Ikeda, K., Onaka, T., Yamakado, M., Nakai, J., Ishikawa, T., Taketo,
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